Message From Local Pharmacy Team

NCT05613764 | Completed

• 1 other identifier: 851911-Trial D
• Study Type: interventional
• Target: 520,000
• Locations: 1 country
• Sites: 1

Brief Summary

This experiment is part of a megastudy with a total of ten experimental conditions and a holdout control condition to which patients will be randomly assigned. The focal comparison in this experiment is between a message encouraging vaccination that comes from a patient's local pharmacy team and a control message telling patients that an updated COVID booster vaccine is waiting for them. The intervention testing if text messages encouraging vaccination that come from a patient's local pharmacy team will produce more vaccinations than otherwise identical messages.

Conditions

COVID-19

Keywords

COVID-19; behavioral science interventions; vaccination promotion

Outcome Measures

Primary Outcomes (1)

• Patient uptake of COVID bivalent booster

  Whether patients receive a bivalent COVID booster at the pharmacy in question

  During the 30 days after receiving the SMS/MMS intervention

Secondary Outcomes (2)

• Patient uptake of COVID bivalent booster

  60 days after receiving the SMS/MMS intervention

• Patient uptake of COVID bivalent booster

  90 days after receiving the SMS/MMS intervention

Study Arms (2)

Control condition with "waiting for you" message

EXPERIMENTAL

This control condition will use the text message that the investigators found to be the best performing in their last mega-study of vaccine text messages to recommend a COVID vaccination.

Behavioral: COVID Booster text messages

Message from local pharmacy team

EXPERIMENTAL

This condition will use a text message from the participant's local pharmacist recommending a COVID vaccination.

Behavioral: COVID Booster text messages

Interventions

COVID Booster text messages BEHAVIORAL

Participants will receive text messages per descriptions listed in the arms

Control condition with "waiting for you" message; Message from local pharmacy team

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may not qualify if:

• The patient unsubscribed from texts before the send date and time of the patient's SMS/MMS message
• The patient received a bivalent COVID booster before the send date and time of the patient's SMS/MMS message.

Sponsors & Collaborators

• University of Pennsylvania: lead

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: CARE PROVIDER, OUTCOMES ASSESSOR
• Masking Details: As treated participants will receive text messages, there is no scope for blinding. Care providers will not be made aware of subjects' participation in the study, or assigned treatment arms. The study team will only receive data on subjects' assigned arms and outcomes at the end of the study.
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: Participants will be randomly assigned to the different arms.

Study Record Dates

• First Submitted: November 4, 2022
• First Posted: November 14, 2022
• Study Start: November 3, 2022
• Primary Completion: December 8, 2022
• Study Completion: February 6, 2023
• Last Updated: March 3, 2023

Record last verified: 2023-03

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)